Fig. 3
From: Characteristics of the vaginal microbiome in women with premature ovarian insufficiency
Metabolic pathways that differed significantly between the POI and control groups. NG, healthy control group; POI, premature ovarian insufficiency; PWY-7199, pyrimidine deoxyribonucleosides salvage; GLYCOCAT-PWY, glycogen degradation I; ARGORNPROST-PWY, L-arginine degradation; PWY-7323, superpathway of GDP-mannose-derived O-antigen building blocks biosynthesis; PWY-6123, inosine-5′-phosphate biosynthesis I; PWY-7200, superpathway of pyrimidine deoxyribonucleoside salvage; PWY-6609, adenine and adenosine salvage III; CALVIN-PWY, Calvin-Benson-Bassham cycle; PWY-6121, 5-aminoimidazole ribonucleotide biosynthesis I; PWY-6122, 5-aminoimidazole ribonucleotide biosynthesis II; PWY-6277, superpathway of 5-aminoimidazole ribonucleotide biosynthesis; PWY-7196, superpathway of pyrimidine ribonucleosides salvage; LACTOSECAT-PWY, lactose and galactose degradation I; PWY-5913, (partial TCA cycle obligate autotrophs); PWY-7184, pyrimidine deoxyribonucleotides de novo biosynthesis I; PWY-6163, chorismate biosynthesis from 3-dehydroquinate